Sleep-disordered breathing patterns and prognosis in pulmonary arterial hypertension: A cluster analysis of nocturnal cardiorespiratory signals.

[1]  V. Somers,et al.  Whom to Screen and How to Screen for Obstructive Sleep Apnea in the Cardiology Clinic. , 2023, Circulation.

[2]  Xin Li,et al.  The comorbidity burden and disease phenotype in pre-capillary pulmonary hypertension: The contributing role of obstructive sleep apnea. , 2022, Sleep medicine.

[3]  Xin Li,et al.  Implication of prolonged nocturnal hypoxemia and obstructive sleep apnea for pulmonary hemodynamics in patients being evaluated for pulmonary hypertension: a retrospective study. , 2022, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[4]  M. Humbert,et al.  2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, European heart journal.

[5]  H. Greenberg,et al.  Comparison of obstructive sleep apnoea prevalence and severity across WHO pulmonary hypertension groups , 2022, BMJ Open Respiratory Research.

[6]  D. Gozal,et al.  Sleep-Disordered Breathing in Adults with Precapillary Pulmonary Hypertension: Prevalence and Predictors of Nocturnal Hypoxemia , 2022, Lung.

[7]  Robert A. Lewis,et al.  Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis , 2022, The Lancet. Respiratory medicine.

[8]  Xin Li,et al.  The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea , 2021, BMC Pulmonary Medicine.

[9]  S. Rosenkranz,et al.  COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension , 2021, European Respiratory Journal.

[10]  S. Redline,et al.  Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. , 2021, Circulation.

[11]  Farhan A Shah,et al.  Obstructive Sleep Apnea and Pulmonary Hypertension: A Review of Literature , 2021, Cureus.

[12]  A. Pack,et al.  Metrics of Sleep Apnea Severity: Beyond the AHI. , 2021, Sleep.

[13]  J. Rowley,et al.  Oxygen Therapy in Sleep Disordered Breathing. , 2021, Chest.

[14]  L. Harbaum,et al.  Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry. , 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  A. Malhotra,et al.  Obstructive sleep apnea and pulmonary hypertension: a bidirectional relationship. , 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[16]  M. Humbert,et al.  Sleep-related breathing disorders and pulmonary hypertension , 2020, European Respiratory Journal.

[17]  P. Schumacker,et al.  Role of Hypoxia-Inducible Factors in Regulating Right Ventricular Function and Remodeling during Chronic Hypoxia-Induced Pulmonary Hypertension. , 2020, American journal of respiratory cell and molecular biology.

[18]  Jiyan Chen,et al.  Impact of obstructive sleep apnea on left ventricular mass index in men with coronary artery disease. , 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[19]  Thomas Penzel,et al.  On the rise and fall of the apnea−hypopnea index: A historical review and critical appraisal , 2020, Journal of sleep research.

[20]  R. Mehra,et al.  Pulmonary artery hemodynamics are associated with duration of nocturnal desaturation but not apnea-hypopnea index. , 2020, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[21]  J. Barberà,et al.  Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension , 2019, Respiratory Research.

[22]  F. Fedele,et al.  Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  S. Redline,et al.  Composition of nocturnal hypoxaemic burden and its prognostic value for cardiovascular mortality in older community-dwelling men. , 2018, European heart journal.

[24]  A. Goda,et al.  Nocturnal Hypoxemia, But Not Sleep Apnea, Is Associated With a Poor Prognosis in Patients With Pulmonary Arterial Hypertension. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[25]  J. Sowers,et al.  Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness , 2018, Hypertension.

[26]  A. Kwaśnik,et al.  Perspective: Sleep at the USA Science and Engineering Festival-A New Outreach for the American Academy of Sleep Medicine. , 2018, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[27]  Susheel P. Patil,et al.  Portable Sleep Monitoring for Diagnosing Sleep Apnea in Hospitalized Patients With Heart Failure , 2018, Chest.

[28]  M. Goumans,et al.  Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension , 2017, Circulation.

[29]  S. Redline,et al.  Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science. , 2017, Circulation.

[30]  M. Humbert,et al.  Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension , 2017, European Respiratory Journal.

[31]  A. Pack,et al.  Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences. , 2017, Journal of the American College of Cardiology.

[32]  E. A. Sykes,et al.  Hypoxic Pulmonary Vasoconstriction: From Molecular Mechanisms to Medicine , 2017, Chest.

[33]  Yong-xiang Wei,et al.  Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system , 2016, Journal of geriatric cardiology : JGC.

[34]  R. Heinzer,et al.  Scoring criteria for portable monitor recordings: a comparison of four hypopnoea definitions in a population-based cohort , 2015, Thorax.

[35]  R. Speich,et al.  Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with pre-capillary pulmonary hypertension and sleep-disturbed breathing: randomized, double-blind, cross-over trial. , 2015, European heart journal.

[36]  P. Willeit,et al.  Left Ventricular Mass and the Risk of Sudden Cardiac Death: A Population‐Based Study , 2014, Journal of the American Heart Association.

[37]  J. Granton,et al.  Sleep disordered breathing in group 1 pulmonary arterial hypertension. , 2014, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[38]  M. Humbert,et al.  Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension. , 2012, American journal of respiratory and critical care medicine.

[39]  M. Narasimhan,et al.  Correlation of pulmonary hypertension severity with metrics of comorbid sleep-disordered breathing , 2011, Sleep and Breathing.

[40]  R. Naeije,et al.  Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension. , 2010, American journal of respiratory and critical care medicine.

[41]  B. Cowan,et al.  Left ventricular hypertrophy and renin-angiotensin system blockade , 2009, Current hypertension reports.

[42]  E. Benjamin,et al.  Left Ventricular Morphology and Systolic Function in Sleep-Disordered Breathing: The Sleep Heart Health Study , 2008, Circulation.

[43]  M. Humbert,et al.  High occurrence of hypoxemic sleep respiratory disorders in precapillary pulmonary hypertension and mechanisms. , 2013, Chest.